Schedule I [21 CFR 1308.11]
Source: Shulgin, Alexander T. Controlled Substances: Chemical & Legal Guide to Federal Drugs Laws (2nd edition). Ronin Publishing Inc., Berkeley, 1992
Source: DEA Office of Diversion Control: Section 1308: Schedules of Controlled Substances
(d)
Hallucinogenic substances. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation, which contains any quantity of the following hallucinogenic substances, or which contains any of its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation (for purposes of this paragraph only, the term “isomer” includes the optical, position and geometric isomers):
Effective 12 Sep 1994, 59 FR 46757 added:
(1)
7249
Alpha-ethyltryptamine (Etryptamine; Monase; α-Ethyl-1H-indole-3-ethanamine; 3-(2-Aminobutyl)indole; α-ET; AET)
CA: CDSA Schedule III Section 28 Etryptamine
UK: MDA Part I Class A Section 1(a) Etryptamine
UN: Psychotropics Schedule I Etryptamine
Effective 21 Sep 1973, 38 FR 26447 added:
On 2 Jul 1973, 38 FR 17499 proposed to add:
(2)
7391
4-Bromo-2,5-dimethoxyamphetamine (4-Bromo-2,5-dimethoxy-α-methylphenethylamine; 4-Bromo-2,5-DMA)
CA: CDSA Schedule I Section 19 Subsection 14 4-Bromo-2,5-dimethoxyamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 15 4-Bromo-2,5-dimethoxyamphetamine
UK: MDA Part I Class A Section 1(a) 4-Bromo-2,5-dimethoxy-α-methylphenethylamine and Section 1(f) 4-Bromo-2,5-dimethoxy-α-methylphenethylamine
UN: Psychotropics Schedule I Brolamfetamine (DOB)
Effective 2 Jun 1995, 60 FR 28718 added:
On 20 Dec 1994, 59 FR 65521 proposed to add:
(3)
7392
4-Bromo-2,5-dimethoxyphenethylamine (2-(4-Bromo-2,5-dimethoxyphenyl)-1-aminoethane; Alpha-desmethyl DOB; 2C-B; Nexus)
CA: CDSA Schedule III Section 24 4-Bromo-2,5-dimethoxybenzeneethanamine
UK: MDA Part I Class A Section 1(c) 4-Bromo-2,5-dimethoxyphenethylamine
UN: Psychotropics Schedule II 2 C-B
Effective 21 Sep 1973, 38 FR 26447 added:
On 31 May 1973, 38 FR 14288 proposed to add:
(4)
7396
2,5-Dimethoxyamphetamine (2,5-Dimethoxy-α-methylphenethylamine; 2,5-DMA)
CA: CDSA Schedule I Section 19 Subsection 5 2,5-Dimethoxyamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 6 2,5-Dimethoxyamphetamine
UK: MDA Part I Class A Section 1(c) 2,5-Dimethoxyamphetamine
UN: Psychotropics Schedule I DMA
Effective 16 Feb 1993, 58 FR 4316 added:
(5)
7399
2,5-Dimethoxy-4-ethylamphetamine (DOET)
CA: CDSA Schedule I Section 19 Subsection 13 4-Ethyl-2,5-dimethoxyamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 14 4-Ethyl-2,5-dimethoxyamphetamine
UK: MDA Part I Class A Section 1(c) 4-Ethyl-2,5-dimethoxyamphetamine
UN: Psychotropics Schedule I DOET
⇒
PubChem: 27402; ChemSpider: 25499; PiHKAL • info: DOET; Wikipedia: 2,5-Dimethoxy-4-ethylamphetamine
Effective 18 Mar 2004, 69 FR 12794 added (and renumbered subsequent entries):
On 8 Sep 2003, 68 FR 52872 proposed to add (and to renumber subsequent entries):
(6)
7348
2,5-Dimethoxy-4-(n)-propylthiophenenthylamine (2C-T-7), its optical isomers, salts and salts of isomers
Effective 21 Sep 1973, 38 FR 26447 added:
On 2 Jul 1973, 38 FR 17499 proposed to add:
(7)
7411
4-Methoxyamphetamine (4-Methoxy-α-methylphenethylamine; Paramethoxyamphetamine; PMA)
CA: CDSA Schedule I Section 19 Subsection 6 4-Methoxyamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 7 4-Methoxyamphetamine
UK: MDA Part I Class A Section 1(c) 4-Methoxyamphetamine
UN: Psychotropics Schedule I PMA
(8)
7401
5-Methoxy-3,4-methylenedioxyamphetamine
CA: CDSA Schedule I Section 19 Subsection 10 5-Methoxy-3,4-methylenedioxyamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 11 5-Methoxy-3,4-methylenedioxyamphetamine
UK: MDA Part I Class A Section 1(c) 5-Methoxy-3,4-methylenedioxyamphetamine
UN: Psychotropics Schedule I MMDA
⇒
PubChem: 26175; ChemSpider: 24386; Drugs Forum: MMDA; PiHKAL • info: MMDA; Wikipedia: MMDA (psychedelic)
(9)
7395
4-Methyl-2,5-dimethoxyamphetamine (4-Methyl-2,5-dimethoxy-α-methylphenethylamine; DOM; STP)
CA: CDSA Schedule I Section 19 Subsection 3 4-Methyl-2,5-dimethoxyamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 4 4-Methyl-2,5-dimethoxyamphetamine
UK: MDA Part I Class A Section 1(a) 2,5-Dimethoxy-α,4-dimethylphenethylamine and Section 1(f) 2,5-Dimethoxy-α,4-dimethylphenethylamine
UN: Psychotropics Schedule I STP (DOM)
(10)
7400
3,4-Methylenedioxyamphetamine
CA: CDSA Schedule I Section 19 Subsection 4 3,4-Methylenedioxyamphetamine (MDA)
CA: [revoked] CDSA Schedule III Section 1 Subsection 5 3,4-Methylenedioxyamphetamine (MDA)
UK: MDA Part I Class A Section 1(c) 3,4-Methylenedioxyamphetamine
UN: Psychotropics Schedule I Tenamfetamine (MDA)
Effective 23 Mar 1988, 53 FR 5156 added:
Effective 27 Jan 1988, 53 FR 2225 revoked:
Effective 13 Nov 1986, 51 FR 36552 added (and renumbered subsequent entries):
(11)
7405
3,4-Methylenedioxymethamphetamine (MDMA)
[With thanks to Noel at NIH/NCGC for noticing this entry was botched.]
CA: CDSA Schedule I Section 19 Subsection 8 N-Methyl-3,4-methylenedioxyamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 9 N-Methyl-3,4-methylenedioxyamphetamine
UK: MDA Part I Class A Section 1(c) N-Methyl-3,4-methylenedioxyamphetamine
UN: Psychotropics Schedule I MDMA
Effective 13 Apr 1989, 54 FR 14797 added (and renumbered subsequent entries):
(12)
7404
3,4-Methylenedioxy-N-ethylamphetamine (N-Ethyl-alpha-methyl-3,4(methylenedioxy)phenethylamine; N-Ethyl MDA; MDE; MDEA)
CA: CDSA Schedule I Section 19 Subsection 12 N-Ethyl-3,4-methylenedioxyamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 13 N-Ethyl-3,4-methylenedioxyamphetamine
UK: MDA Part I Class A Section 1(c) N-Ethyl-3,4-methylenedioxyamphetamine
UN: Psychotropics Schedule I MDE (N-Ethyl MDA)
Effective 13 Apr 1989, 54 FR 14797 added (and renumbered subsequent entries):
(13)
7402
N-Hydroxy-3,4-methylenedioxyamphetamine (N-Hydroxy-alpha-methyl-3,4(methylenedioxy)phenethylamine; N-Hydroxy MDA)
CA: CDSA Schedule I Section 19 Subsection 20 N-Hydroxy-3,4-methylenedioxyamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 21 N-Hydroxy-3,4-methylenedioxyamphetamine
UK: MDA Part I Class A Section 1(a) N-Hydroxy-tenamphetamine and Section 1(f) N-Hydroxytenamphetamine
UN: Psychotropics Schedule I N-Hydroxy MDA
(14)
7390
3,4,5-Trimethoxyamphetamine
CA: CDSA Schedule I Section 19 Subsection 21 3,4,5-Trimethoxyamphetamine
CA: [revoked] CDSA Schedule III Section 1 Subsection 22 3,4,5-Trimethoxyamphetamine
UK: MDA Part I Class A Section 1(c) 3,4,5-Trimethoxyamphetamine
UN: Psychotropics Schedule I TMA
⇒
PubChem: 31016; ChemSpider: 28775; Bluelight: TMA and isomers; Drugs Forum: TMA 2; Erowid: TMA-2 (and other TMAs); PiHKAL • info: TMA; Wikipedia: Trimethoxyamphetamine
Effective 19 Jan 2011, 75 FR 79296 added (and renumbered subsequent entries):
Effective 28 Oct 2009, 74 FR 55502 extended the comment period of the earlier proposal to 27 Nov 2009 from 21 Sept 2009
On 21 Aug 2009, 74 FR 42217 proposed to add (and to renumber subsequent entries):
(15)
7431
5-Methoxy-N,N-dimethyltryptamine (5-Methoxy-3-[2-(dimethylamino)ethyl)]indole; 5-MeO-DMT), its isomers, salts and salts of isomers
On 1 Mar 2012, 77 FR 12508 proposed to add (and to renumber subsequent entries):
(18)
On 1 Mar 2012, 77 FR 12508 proposed to add:
(i)
1-Butyl-3-(1-naphthoyl)indole (JWH-073)
US: Currently at CSA Schedule I Section g Subsection 4 1-Butyl-3-(1-naphthoyl)indole
On 1 Mar 2012, 77 FR 12508 proposed to add:
(ii)
5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol (CP 47,497)
US: Currently at CSA Schedule I Section g Subsection 1 5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol
On 1 Mar 2012, 77 FR 12508 proposed to add:
(iii)
5-(1,1-Dimethyloctyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol (Cannabicyclohexanol; CP 47,497 C8 homologue)
US: Currently at CSA Schedule I Section g Subsection 2 5-(1,1-Dimethyloctyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol
On 1 Mar 2012, 77 FR 12508 proposed to add:
(iv)
1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole (JWH-200)
US: Currently at CSA Schedule I Section g Subsection 6 1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole
On 1 Mar 2012, 77 FR 12508 proposed to add:
(v)
1-Pentyl-3-(1-naphthoyl)indole (JWH-018; AM678)
US: Currently at CSA Schedule I Section g Subsection 3 1-Pentyl-3-(1-naphthoyl)indole
(18)
7434
Diethyltryptamine (N,N-Diethyltryptamine; DET)
CA: CDSA Schedule III Section 6 N,N-Diethyltryptamine
UK: MDA Part I Class A Section 1(a) N,N-Diethyltryptamine
UN: Psychotropics Schedule I DET
(19)
7435
Dimethyltryptamine (DMT)
CA: CDSA Schedule III Section 7 N,N-Dimethyltryptamine
UK: MDA Part I Class A Section 1(a) N,N-Dimethyltryptamine
UN: Psychotropics Schedule I DMT
Effective 29 Sep 2004, 69 FR 58050 added (and renumbered subsequent entries):
(20)
7439
5-Methoxy-N,N-diisopropyltryptamine (5-MeO-DIPT), its isomers, salts and salts of isomers
UK: MDA Part I Class A Section 1(b) 5-Methoxy-N,N-diisopropyltryptamine
⇒
PubChem: 151182; ChemSpider: 133247; Bluelight: 5-MeO-DiPT; Drugs Forum: 5-MeO-DIPT; Erowid: 5-MeO-DIPT; TiHKAL • info: 5-MeO-DIPT; Wikipedia: 5-Methoxy-diisopropyltryptamine
(22)
7315
Lysergic acid diethylamide
CA: CDSA Schedule III Section 5 Lysergic acid diethylamide
UK: MDA Part I Class A Section 1(a) Lysergide
UN: Psychotropics Schedule I (+)-Lysergide (LSD) (LSD-25)
(26)
7415
Peyote
Meaning all parts of the plant presently classified botanically as Lophophora williamsii Lemaire, whether growing or not, the seeds thereof, any extract from any part of such plant, and every compound, manufacture, salts, derivative, mixture, or preparation of such plant, its seeds or extracts (Interprets 21 USC 812(c), Schedule I(c) (12))
CA: [not controlled] CDSA Schedule III Section 17 Lophophora
⇒
PubChem: 135309929 135330128; Bluelight: Peyote; Drugs Forum: Peyote; Erowid: Peyote; Wikipedia: Peyote
(28)
7484
N-Methyl-3-piperidyl benzilate
CA: CDSA Schedule III Section 8 N-Methyl-3-piperidyl benzilate (LBJ)
(29)
7437
Psilocybin
CA: CDSA Schedule III Section 12 Psilocybin
UK: MDA Part I Class A Section 1(b) Psilocybin
UN: Psychotropics Schedule I Psilocybine
⇒
PubChem: 10624; ChemSpider: 10178; Drugs Forum: 4-H2PO4-DMT; Erowid: Psilocybin & Psilocin; TiHKAL • info: 4-H2PO4-DMT; Wikipedia: Psilocybin
(30)
7438
Psilocyn [sic]
This substance is more commonly spelled Psilocin.
CA: CDSA Schedule III Section 11 Psilocin
UK: MDA Part I Class A Section 1(a) Psilocin
UN: Psychotropics Schedule I Psilocine (Psilotsin)
On 8 Sep 2003, 68 FR 52872 proposed to add (and to renumber subsequent entries):
7494
1-(3-Trifluoromethylphenyl)piperazine (TFMPP)
The proposal to schedule TFMPP was never acted upon. So, once the extended emergency scheduling enacted by 67 FR 59163 expired on 19 Mar 2004, TFMPP was no longer a scheduled substance.
CA: CDSA Schedule III Section 34 Trifluoromethylphenylpiperazine
⇒
PubChem: 4296; ChemSpider: 4145; Bluelight: BZP + TFMPP; Drugs Forum: TFMPP; Erowid: TFMPP; Wikipedia: Trifluoromethylphenylpiperazine
Δ1 cis or trans Tetrahydrocannabinol
Δ6 cis or trans Tetrahydrocannabinol
Δ3,4 cis or trans Tetrahydrocannabinol
(31)
7370
Tetrahydrocannabinols
Meaning Tetrahydrocannabinols naturally contained in a plant of the genus Cannabis (cannabis plant), as well as synthetic equivalents of the substances contained in the cannabis plant, or in the resinous extractives of such plant, and/or synthetic substances, derivatives, and their isomers with similar chemical structure and pharmacological activity to those substances contained in the plant, such as the following:
Meaning Tetrahydrocannabinols naturally contained in a plant of the genus Cannabis (cannabis plant), as well as synthetic equivalents of the substances contained in the cannabis plant, or in the resinous extractives of such plant, and/or synthetic substances, derivatives, and their isomers with similar chemical structure and pharmacological activity to those substances contained in the plant, such as the following:
- Δ1 cis or trans Tetrahydrocannabinol, and their optical isomers
- Δ6 cis or trans Tetrahydrocannabinol, and their optical isomers
- Δ3,4 cis or trans Tetrahydrocannabinol, and its optical isomers
(Since nomenclature of these substances is not internationally standardized, compounds of these structures, regardless of numerical designation of atomic positions covered.)
CA: CDSA Schedule II Section 1 Subsection 7 Tetrahydrocannabinol
UK: MDA Part II Class B Section 1(a) Tetrahydrocannabinol
⇒
PubChem: 16078; ChemSpider: 4479482; Bluelight: Tetrahydrocannabinol; Erowid: Cannabis; Wikipedia: TetrahydrocannabinolUN: Psychotropics Schedule I (6aR,10aR)-6a,7,10,10a-Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol
UN: Psychotropics Schedule I 7,8,9,10-Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol
Effective 25 Oct 1978, 43 FR 43295 added:
(32)
7455
Ethylamine analog of Phencyclidine (N-Ethyl-1-phenylcyclohexylamine; (1-Phenylcyclohexyl)ethylamine; N-(1-Phenylcyclohexyl)ethylamine; Cyclohexamine; PCE)
CA: CDSA Schedule III Section 13 N-(1-Phenylcyclohexyl)ethylamine
UK: MDA Part I Class A Section 1(a) Eticyclidine
UN: Psychotropics Schedule I Eticyclidine (PCE)
Effective 25 Oct 1978, 43 FR 43295 added:
(33)
7458
Pyrrolidine analog of Phencyclidine (1-(1-Phenylcyclohexyl)pyrrolidine; PCPy; PHP)
[With thanks to Noel at NIH/NCGC for noticing this entry was botched.]
CA: CDSA Schedule III Section 16 Rolicyclidine
UK: MDA Part I Class A Section 1(a) Rolicyclidine
UN: Psychotropics Schedule I Rolicyclidine (PHP) (PCPY)
⇒
PubChem: 62436; ChemSpider: 56218; Bluelight: PCP analogs; Drugs Forum: PCP analogs; Erowid: Rolicyclidine synthesis; Wikipedia: Rolicyclidine
Effective 11 Aug 1975, 40 FR 28611b added (and renumbered subsequent entries):
On 29 May 1975, 40 FR 23306 proposed to add (and to renumber subsequent entries):
(34)
7470
Thiophene analog of Phencyclidine (1-[1-(2-Thienyl)cyclohexyl]piperidine; 2-Thienyl analog of Phencyclidine; TPCP; TCP)
CA: CDSA Schedule III Section 14 1-[1-(2-Thienyl)cyclohexyl]piperidine
UK: MDA Part I Class A Section 1(a) Tenocyclidine
UN: Psychotropics Schedule I Tenocyclidine (TCP)
⇒
PubChem: 62751; ChemSpider: 56495; Bluelight: PCP analogs; Drugs Forum: Tenocyclidine; Wikipedia: Tenocyclidine![3D rendering of 1-[1-(2-Thienyl)cyclohexyl]pyrrolidine](data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAKkAAACHCAIAAADiEe4+AAAACXBIWXMAAC4jAAAuIwF4pT92AAAAHXRFWHRTb2Z0d2FyZQBHUEwgR2hvc3RzY3JpcHQgOC42MG0jaeMAAAgFSURBVHic7Z0xiNxGFEDnEse4M0Oaq45DRboDg1ymuEKdGzcSJq1BiwvXo8J9pN44aCtXKbS4P9AGQ1Jc4V1ibGzDgpRLgg9SRPKBHQK+oBQ/DLJ2s7en1czs6v9X3cleSac3M39mNPN3p6oqRqDkM9M3QBiD3OOF3OOF3OOF3OOF3OOF3OOF3OOF3OOF3OOF3OOF3OOF3OOF3OOF3OOF3OOF3OOF3OOF3OOF3OPFmPuTk5MHDx6UZWnqBowzGo3G47HJO6gMcXBwcPXqVcaY67pxHBdFYepONDOZTIQQlmXB80/T1NSdmHEvhOCcTyaTJEl83+ec974Q1JXbth2GYZZlrutyzk39yQbcJ0nCGIvjuHHQdV2oCn0qBHXllmWBcvmvRVFYluU4jpF70+0+yzLOue/78kgYhlJzURRxHDcKgeY77ISGciHEZDL5v//JGBNCaL7DSr9727Zt25ayhRCMsXpVAOqFAMpKkiSab7UFWZaFYWjb9oXK64RhaCTwa3Uvwzz8mqYpYywMwyUf2YpC0E55HSOBX5/7RpgvioJz7rruih+HQgDPd0MKQV0557yFcomRwK/J/XyYd13XsqwWJb3xxE2NkTpvivQHfk3uG2G+kwiXZZlt20Z6SVVVXRitWqA58Otw3wjzaxbw+qkcxzHoXoUknYFf+ZzuaDSKoki20mVZep7nOA6U8RaUZdnjmeA4jjnnnudpuJZa93meDwYD3/d934cjg8GgLEvo9xHzcM6TJBmPx0EQqL6WWvee58FkFvwaRdFoNEqSBCZxiYXAjG8URarf9FxRd+ogCPI8T9MUTE+n0yiKhBCO46i7aD8QQkynU8/zYHyk6Cqq6v18mB8MBvU2gFiOhsCvxP18mIc2gML86mgI/ErcN8L8cDgcDodxHMuX1sQqqA783cf7+TAfBIEQQr6dI1ZHaeDvuN4/fvy4HuYZY30N85xzPdMM6gJ/x+7jON7f38cQ5m3bnk6nGi4ErwzG43Ge592euWP3Dx8+PDk5kd0TaAMozK9DWZZRFPm+3/lj7Ni97J5AnSiKQrYBRDs8z+Ocqwia3ffzYfbG87yyLGn+bk2gk69oJlTJGC9JEpjMUXFyPMghkuw4d4sS95zzOI5Ho9FwOFRxfgxA5VnnheeFqJrPd11XCBEEgeM4vezr3b17d3d3V935oyjK8xzWOqhC3dKAoihguU63p2W1RRMG124oBUbFqhckKnyHCy0/BC11V9HMzg67eZM1JnV2drq8BLT2vu+rnglV+/5e26tozSgtzOoGdQ2Ur9mCIR8s11F9LT3EMRsOmaJerNJBXROlEQW47FL85dT3cOmP9/DAwrDivJKL8bt6ipqXaWtaow1bcDrcXAcbeK9du7a/v996R0QLpGbHqWy7gkLYiXvoGuvcnqFvX04URbdv3z49PW19hsZOTcdx7t+/f3h4yBjzfV/PumapuSgqzivYbAIH37x5s86ZYS/6/NZEdRjLvbA6sBFHrvKb36ENq0Kgf6TuNj58+FB9WsWTpGKsCkMZCEK5TeeyBVHPoK7B5rqHbcwrbsArigK29FqW1fmWCTj506dPq7nmXYiKsf8OlmUZhmGLLALzG9b0YMD9+7MXs+f3jo/2jo/2Zs/vvT97Uf/XNE0bO9dXdwmZLCAcdNV4ykZlNptVc+6LorLt+YPN2NRIudAApj7155ow4P71s2/e5o/g57f5o59//Bp+lslXYJdd6x5cmqbQWggh1nmgaZpCoFmnM1FPKgOzHY2/C5ornd1ViQH3x0d79V/P/vwJfriwflwKWOrUrhOQZRksO3AcpysrSZLMZ+IwmHSjMlXvZ8/vSeXqkJ0A27ZXDBzwEc65ZVmKel6NPFumku1URtyff3z3Nn/08vjWsx8O8lfB33/9qvRyWZZB0+267vJGRYZ2PRUxyzKzKaVM9vPPP777bfbt62ffaLhWmqZQ1RZ2AjoJ7VuHbvfHR3uN1r4R/pUCQ3B4wQhHVIT2bUG3+/xV8PL4FozrdNZ7iVw+enh4eOfOHeh5GU/dY4SdqqrUvCRazD/nZ6e/fPfH79+ffzy78sX1L3dv7X0VfH7lus57YIwFQRBFEWPsxo0bT5486eXKoosxXfh0Uw/t9c4dnjAvQeRetvaN0C4HdVuaw7M1WNwvF1wvFgYTW2um/+5hdLdKwz6ZTFCN9PrsfvVZnTqaZ3gM0k/3LWZz5z+udGZ3E+ih+3Xe4tTp/bRPr9x39fa2cc6+dgJ64l51He1lJ6AP7vXE5v51ArbbfZIkmqujimVhpthu97DlQ78D6Fh0tdvEFNv9vZhlWapIRHMhjuM4jrPtu8y22z2xDuQeL+QeL+QeL+QeL+QeL+QeL+QeL+QeL+QeL+QeL+QeL+QeL+QeL+QeL+QeL+QeL+QeL+QeL+QeL+QeL+QeL9vtnnM+GAz0fyFLFEXD4XDrv/nR9AaBtZC7ZLTt0Fiep2+72G73gB4f7TI5bDJ9cA9A3kQVKZPWzOSwsfTHfaUmZdJ8Ks7e0Cv3QFcpk/oU2hfSQ/fAOtkS+rTRegm9dV99mi3hUvnzmZrv3dk0+uweWL0Sd5WkaVvov3tgeRomFUmaNh8s7oGF+fMxhPaF4HJffTpYxxPaF4LOPQDjQDyhfSG6vzuB2By2+z0esQ7kHi/kHi/kHi/kHi/kHi/kHi/kHi/kHi/kHi/kHi/kHi/kHi/kHi/kHi/kHi/kHi/kHi/kHi/kHi//AiGGkM1KyAkHAAAAAElFTkSuQmCC "Click for a 3D rendering of 1-[1-(2-Thienyl)cyclohexyl]pyrrolidine")
On 5 Jul 2011, 76 FR 39039 proposed to add:
(36)
7350
Marihuana extract
UN: Narcotics Part 1 Section 1 Extracts and tinctures of cannabis
Effective 4 Jan 2013, 78 FR 664 finalized the prior interim scheduling:
Effective 9 Jul 2012, S. 3187, 112 Cong., 2nd Sess. added:
(36)
1248
4-Methylmethcathinone (Mephedrone)
EU: Substances Substances 4-Methylmethcathinone
UK: MDA Part II Class B Section 1(aa) 4-Methylmethcathinone; Mephedrone
⇒
PubChem: 45266826; ChemSpider: 21485694; Bluelight: Mephedrone; Drugs Forum: Mephedrone; Erowid: 4-Methylmethcathinone / Mephedrone; Wikipedia: Mephedrone
Effective 4 Jan 2013, 78 FR 664 finalized the prior interim scheduling:
Effective 9 Jul 2012, S. 3187, 112 Cong., 2nd Sess. added:
(37)
7535
3,4-Methylenedioxypyrovalerone (MDPV)
CA: CDSA Schedule I Section 17.1 Methylenedioxypyrovalerone
EU: Substances Substances 3,4-Methylenedioxypyrovalerone
UK: MDA Part II Class B Section 1(aa) MDPV
Effective 4 Jan 2013, 78 FR 664 finalized the prior interim scheduling:
Effective 9 Jul 2012, S. 3187, 112 Cong., 2nd Sess. added:
(38)
7509
Effective 4 Jan 2013, 78 FR 664 finalized the prior interim scheduling:
Effective 9 Jul 2012, S. 3187, 112 Cong., 2nd Sess. added:
(39)
7508
Effective 4 Jan 2013, 78 FR 664 finalized the prior interim scheduling:
Effective 9 Jul 2012, S. 3187, 112 Cong., 2nd Sess. added:
(40)
7519
Effective 4 Jan 2013, 78 FR 664 finalized the prior interim scheduling:
Effective 9 Jul 2012, S. 3187, 112 Cong., 2nd Sess. added:
(41)
7518
![3D rendering of 2-[4-(Ethylthio)-2,5-dimethoxyphenyl]ethanamine](data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAO0AAACMCAIAAAAfh7knAAAACXBIWXMAAC4jAAAuIwF4pT92AAAAHXRFWHRTb2Z0d2FyZQBHUEwgR2hvc3RzY3JpcHQgOC43MQM/aDQAAAhjSURBVHic7d1NixtHGgfwR9lAiGEYSjlsvLAOkSCwgcBCC3xJbq1Tzj0Hf4AW/gJu3XxMz8m3MRp83T3o4kvACVIwZA0OTA+DCbFh4tIQ7wvLgtX2grNZ26FyqElH03qXqrpGT/9/GCNaUleh/qv6UY9UVVFKEcCGe8N1BwAMQI6BA+QYOECOgQPkGDhAjoED5Bg4QI6BA+QYOECOgQPkGDhAjoED5Bg4QI6BA+QYOECOgQPkGDhAjoED5Bg4QI6BA1Y5TtPUdRfADT45Pjw8rNfrrnsBbvDJcZqmGI9Li0+OocyQY+AAOQYOkGPgADkGDpBj4AA5Bg6QY+AAOQYOkGPgADkGDpBj4AA5Bg6QY+AAOQYO+OS4Wq36vu+6F+BGBevnAQN8xmMoMxY5TlNqtahapUqFqlVqtQg/cLKmUqFGI/8CVyr5G+N3WbX5OU5TqtdJCEoSUoqShISgeh1Rtqrddt2Dsza/Pm61SAiK4zMb221KU+p0HPWJs0qFkoQaDep0KAx/26hzlN0YfXwREVObTgglZX6jlEqIwrrQ7XbDMOz1eoW1mInjOAgCOf4KWKMjE8dKCJUkZzaO3sg93nqvimjEqmmvUyGvX5Ik+mKf53lEVGSker1erVYjIv1/FEXD4bCAdrPX1feV5ynd5miOx/9pYag8T/m+6nYt9Mr8LgvmaDweDodhGBKR7/t6JO52u7VaTQhhO1JSyiAIRt82cRwLIYQQnU7HXrtalsvhUAmhwvDMxmnjcaejouj0WZ5noVfmd1mwMDx9hUZFkX6BHz16ZKPNKIqEELVabTw3M+5a33A4jKJIj8G5Mia7y/M8GxWOlPLOnTvqbFK7XUWk4nh+jqX8bbRBjifRw0IUnb5OUqooUkLoE14cx77vJ1kdt7ZFBt3xodqITqejB904jqc9Rkqp6xyDFY5+hwghbt68qcaSGkVniofZ9bGUKgiUjXPG5udYKTUcqjBUQiii01Pdrwk7OTnRxzUMwzXP9VkpHIZhLiK+748PkKOPX7PpXq+n6+8FKxaDFU6n08l2pbfkkqrrhEVyHEXK85SlD8MscjzP+MFYytzxdcYoOBqpFZrOSmHf95cdX9escHq9nqn3oVKq21VBsOY+ZilFjtXMynK2xdOQXUDIjYLZeblWq3UX/qy+2rPGd7JChTP6LFMlWXaxQv8zriw51pYa3lY7O0+7dCClXDwca55AcmZUROOsfk61p1w51uaWm6On1BU+Lc24dDD3ZG32bD5qboVT2HVDG8qYY23ix//RUXPNSw0ziuaJTds4m+dMq1WWGrDPp/LmWJ0tmm/fvm3jlDptkMvV60WezUffq3fv3rV61bkwpc6xlg2cW1tblk6p02Ka1evFn82zAmZ7e3uzSuGJkONTly9fHi0cjZ/ZZ1w68H3fyOe5Fezt7W1cKTzR5n//2JCtra3sdr/fbzQaZvevr2AkSUJEzWaz1WoNBgOzTazg6tWrQgjXvTAAOS6ULkO73W6/32+1Wq67w8ebrjtQRkEQ6LIYTMF4DBwgx8ABcgwcIMfAAXIMHCDHwAFyDBwgx8ABcgwcIMfAAXIMHCDHwAFyDBwgx8ABcgwcIMfAAXLsQL/fbzabOzs7rjvCB3I8gZ5cwsaeB4PBzs5Os9kkIv2DezDifOW43++fh19fep4npTS7zzRN2+12vV4/PDzs9XrZnEZghusfbJ/KJvmjApcI0LIpUS5evGhpJods0rfc1MVZ0xcuXGAwiYRD7nOcmz8qmzOqmOOaJezGjRs2Jt+eNgmnGpkd6/r16zaaLhWXOZ42l6vtJQK0iQkzONNZtqvx+d0mTpTIYJI1h5zleO4qAdk4bfy4zl18YM2ZJ2dMHTR34tqNnvTSIQc5XmqVALPHdanZvFeYO3B0Qsvcs1ZreuUZvMum0ByvvEqAkeO6yDoxOUvN5z46+fZ4KazvWrzppeb9hoJyvPKyBpl1juuy68TkzKh0c/sfn3x7zXm57U3rzUwROV5hIJwmO64LJnKddWJydIUzsekgCMbfXQYHVLPLLLBkN8eWhpPsjXFycqKUev3q2eC79sFXH93/4tLBVx8Nvmv/9OMPSqnj42PjVeYiK4caWaJm2j7v3buXbZq22loJ2cqx7fJOH1ddojw8uPLk+LPXr54ppV6/evbPwd639z9VSunJ1i01Pe2y4JoLjc0mpXzw4IHuxIzVL0vIfI5tjEbTvHjxQil1/4tLue3Pn/5NKfXy5Ut7TY9fvCv0AvDM1YhLyHCO9R8XCq7kHh5ceXhw5em/P9dDcpGyP6ZkVXhBf5BztDr8uVVRShn8tsbu7u5gMNBFpMHdzvWff/z1xX+/ff70HhG98+6nf3j/6u/e3C6s9d3d3X6/HwSBLqWKUKnQxAM3bTt3hnPs3P//9+RfJzd/+vHJnxp/cd0Xm6pVShL69ZtVpwYDajRoOHTUJ5fO1/c2V/PNl+9lt996+9L7H36mB2bOgoD29/Mb9/eprNPcc1hX4fd/vPL372NdS/z8+vmT43j7nY9dd8qyOKZ6nYgoDKlWo8GA9vdpf59Mf216U3AYjy990Caio68/+ebL946+/oSIPvjznutOWSYESUlpSo0GVSrUaFCakpTEYvGlFXCrj6GcOIzHZXbr1q1r16657oV7yPFme/z48dHRketeuIccAwfIMXCAHAMHyDFwgBwDB8gxcIAcAwfIMXCAHAMHyDFwgBwDB8gxcIAcAwfIMXCAHAMHyDFwgBwDB8jxZrO3RNpmwe9MgQOMx8ABcgwcIMfAAXIMHCDHwAFyDBwgx8ABcgwcIMfAAXIMHCDHwAFyDBwgx8ABcgwcIMfAAXIMHCDHwAFyDBwgx8ABcgwc/AI4IagQuFzT3QAAAABJRU5ErkJggg== "Click for a 3D rendering of 2-[4-(Ethylthio)-2,5-dimethoxyphenyl]ethanamine")
Effective 4 Jan 2013, 78 FR 664 finalized the prior interim scheduling:
Effective 9 Jul 2012, S. 3187, 112 Cong., 2nd Sess. added:
(42)
7585
![3D rendering of 2-[4-(Isopropylthio)-2,5-dimethoxy-phenyl]ethylamine](data:image/png;base64,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 "Click for a 3D rendering of 2-[4-(Isopropylthio)-2,5-dimethoxy-phenyl]ethylamine")
Effective 4 Jan 2013, 78 FR 664 finalized the prior interim scheduling:
Effective 9 Jul 2012, S. 3187, 112 Cong., 2nd Sess. added:
(43)
7532
2-[4-(Isopropylthio)-2,5-dimethoxy-phenyl]ethylamine (2C-T-4)
UK: MDA Part I Class A Section 1(c) 4-Isopropylthio-2,5-dimethoxyphenethylamine and 4-Isopropylthio-2,5-dimethoxyphenethylamine
Effective 4 Jan 2013, 78 FR 664 finalized the prior interim scheduling:
Effective 9 Jul 2012, S. 3187, 112 Cong., 2nd Sess. added:
(44)
7517
2-(2,5-Dimethoxyphenyl)ethanamine (2C-H)
UK: MDA Part I Class A Section 1(c) 2,5-Dimethoxyphenethylamine
Effective 4 Jan 2013, 78 FR 664 finalized the prior interim scheduling:
Effective 9 Jul 2012, S. 3187, 112 Cong., 2nd Sess. added:
(46)
7524
Effective 12 Apr 2013, 78 FR 21818 added:
On 17 Oct 2012, 77 FR 63766 proposed to add:
(47)
7540
3,4-Methylenedioxy-N-methylcathinone (Methylone)
In the few months between the proposed and final ruling this section of the schedule has grown by 28 per cent.
On 13 Nov 2015, 80 FR 70649 proposed to add:
(48)
7538
2-(4-Iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25I-NBOMe; 2C-I-NBOMe)
EU: Substances Substances 2-(4-Iodo-2,5-dimethoxy)-N-(2-methoxybenzyl) phenethylamine
UK: MDA Part I Class A Section 1(f) 2-(4-Iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
UK: [revoked] MDA Temporary Class Drug Orders 2013 2-(4-Iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
See also CSA Schedule I Section h Subsection 4 2-(4-Iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine
On 13 Nov 2015, 80 FR 70649 proposed to add:
(49)
7537
2-(4-Chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25C-NBOMe; 2C-C-NBOMe)
UK: MDA Part I Class A Section 1(f) 2-(4-Chloro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
UK: [revoked] MDA Temporary Class Drug Orders 2013 2-(4-Chloro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
See also CSA Schedule I Section h Subsection 5 2-(4-Chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine
On 13 Nov 2015, 80 FR 70649 proposed to add:
(50)
7536
2-(4-Bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25B-NBOMe; 2C-B-NBOMe)
UK: MDA Part I Class A Section 1(f) 2-(4-Bromo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
UK: [revoked] MDA Temporary Class Drug Orders 2013 2-(4-Bromo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
See also CSA Schedule I Section h Subsection 6 2-(4-Bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine
11 March 2016 · 
· Isomer Design
· Isomer Design